Celltrion
068270.KS
#756
Rank
C$44.44 B
Marketcap
C$203.17
Share price
1.40%
Change (1 day)
21.24%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): C$2.64

According to Celltrion 's latest financial reports the company's current EPS (TTM) is C$2.59. In 2024 the company made an earnings per share (EPS) of C$1.84 a decrease over its 2023 EPS that were of C$3.64.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$2.6443.47%
2024C$1.84-49.57%
2023C$3.64-2.08%
2022C$3.72-11.72%
2021C$4.212.03%
2020C$4.1382.8%
2019C$2.2618.31%
2018C$1.91-36.33%
2017C$3.00161.25%
2016C$1.152.86%
2015C$1.1217.84%
2014C$0.955.87%
2013C$0.89-70.85%
2012C$3.07134.09%
2011C$1.3143.59%
2010C$0.9174.49%
2009C$0.52317.8%
2008C$0.13-71.7%
2007C$0.44